한글목차

세계 간췌담도 외과용 수술기구 시장은 개복수술 및 최소침습수술 시장에서의 기회를 배경으로 미래가 밝을 것으로 예상됩니다. 세계 간췌담도 외과용 수술기구 시장은 2025년부터 2031년까지 CAGR 7.4%로 성장할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 간 질환의 유병률 증가, 최소침습 수술에 대한 수요 증가, 수술 기술의 발전입니다.

• Lucintel의 예측에 따르면, 유형별로는 내시경 수술이 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상됩니다.
• 용도별로는 최소침습수술이 더 높은 성장률을 보일 것으로 예상됩니다.
• 지역별로는 아시아태평양(APAC)이 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상됩니다.

간췌담도 외과용 수술기구 시장의 새로운 동향

간췌담도 외과용 수술기구 시장은 이러한 복잡한 수술의 수행 방식을 근본적으로 변화시키는 여러 가지 주요 신흥 트렌드에 의해 재정의되고 있습니다. 이러한 추세는 더 높은 정확도, 환자 결과 개선, 효율성 향상이라는 방향으로 분야를 전환하고 있습니다. 수술 계획부터 시행, 회복에 이르는 과정의 각 단계에 대한 기술 통합에 중점을 두고 있습니다. 이러한 변화는 간췌담도 수술의 높은 복잡성에 대한 대응 필요성과 의료계 전반의 최소침습적이고 효율적인 치료로 전환하는 추세에 따라 추진되고 있습니다.

• 로봇 보조 수술 및 증강현실 보조 수술 : 더 나은 손재주, 정확성, 그리고 수술 영역의 안정적인 시야를 제공하는 로봇 수술 시스템의 적용이 강력한 추세로 보입니다. 이는 특히 복잡한 간담췌장 수술에서 중요합니다. 또한, 증강현실 기술이 접목되어 종양의 위치, 혈관의 경로 등 환자별 정보를 실시간 수술 시야에 겹쳐서 표시할 수 있게 되었습니다. 이를 통해 수술 시 손떨림이 감소하고 좁은 영역에서의 조작성이 향상되어 보다 정확한 정보를 바탕으로 한 수술 판단이 가능해집니다.
• 첨단 에너지 및 혈관 밀봉 장치 : 차세대 에너지 장치 및 혈관 밀봉 장치의 개발은 미래의 중요한 추세입니다. 이 기기들은 고주파 절제, 초음파 에너지, 냉동 절제 등의 신기술을 채택하여 주변 정상 조직에 미치는 열적 영향을 최소화하면서 정확한 조직 절단과 혈관 봉합을 실현합니다. 혈관이 풍부한 HPB 수술에서 이것은 매우 중요합니다. 이를 통해 수술 중 출혈량 대폭 감소, 수술 시간 단축, 환자 회복 촉진 등의 효과를 기대할 수 있습니다.
• 인공지능과 기계학습의 통합 : 인공지능과 기계학습은 간담췌장 수술 장비에 점점 더 많이 통합되고 있습니다. AI 알고리즘은 수술 전 영상 진단을 분석하여 수술 계획을 위한 정밀한 3D 모델을 구축하는 데 활용할 수 있습니다. 수술 중 머신러닝은 조직 특성에 대한 실시간 피드백을 제공하여 최적의 수술 경로를 제안할 수 있습니다. 이를 통해 고도로 개인화된 보다 안전한 수술을 실현하고, AI는 외과 의사를 보조하는 부조종사 역할을 하여 합병증 위험을 줄일 수 있습니다.
• 환자별 및 맞춤형 임플란트 : 환자별 임플란트 및 수술 가이드의 개발로 HPB 수술 영역에서도 맞춤형 의료가 확대되고 있습니다. 3D 프린팅 기술과 첨단 영상 진단을 통해 외과의사는 환자의 해부학적 구조에 정밀하게 맞는 맞춤형 스텐트, 가이드, 모델을 설계할 수 있습니다. 이는 특히 해부학적 변이가 있는 복잡한 케이스에서 필수적입니다. 이를 통해 수술의 정확도가 향상되고 침습성이 감소하여 치료 결과의 개선과 수술 후 합병증 감소로 이어집니다.
• 단일 포트 수술과 NOTES 장치의 진화 : 기존 복강경 수술에서 사용되는 다중 포트와 달리 절개창과 수술 후 통증을 최소화하기 위해 단일 포트 접근과 NOTES(경자연공내수술)의 추세가 진행되고 있습니다. 이에 따라 단일의 작은 절개 부위나 자연공을 통해 정밀하게 조작할 수 있는 고도의 이동성과 유연성을 갖춘 전용 디자인의 수술기구 개발이 요구되고 있습니다. 그 결과, 침습성이 더욱 감소하고, 흉터가 적으며, 환자의 회복 기간을 더욱 단축할 수 있습니다.

이러한 새로운 트렌드는 수술의 안전성 및 정확성 향상과 최소침습화를 실현함으로써 간-담췌장 수술용 의료기기 시장에 혁명을 불러일으키고 있습니다. 지능화, 맞춤화, 최소침습성에 대한 강조는 업계의 판도를 바꾸고, 새로운 진입자를 끌어들이고, 새로운 종류의 수술기구를 만들어내고 있습니다. 이러한 변화는 환자의 수술 경험과 장기적인 건강 결과를 개선하여 궁극적으로 환자의 이익으로 이어집니다.

간췌담도 외과용 수술기구 시장의 최근 동향

간 췌장 담도 외과 수술기구 시장은 기술과 응용 범위를 확대하는 일련의 주요 발전을 이루었습니다. 이러한 발전은 기술 혁신과 첨단 최소침습 치료에 대한 수요로 인해 고도로 전문화된 수술 분야에 혁명을 불러일으키고 있습니다. 이 모든 발전의 최종 결과물로서 점점 더 복잡해지는 임상적 요구의 확대에 대응할 수 있는 성숙하고 다양한 시장이 형성되고 있습니다.

• 차세대 로봇 시스템 도입 : 주요 발전 중 하나는 간췌담도 수술(HPB)을 위해 특별히 설계된 새로운 로봇 수술 시스템의 도입입니다. 이 플랫폼은 관절 가동 범위 향상, 촉각 피드백, 고해상도 영상 처리 기능을 갖추고 있어 복잡한 수술 중 외과의사에게 탁월한 조작성과 가시성을 제공합니다. 그 결과, 간 및 췌장 절제술에서 로봇 수술의 채택률이 급격히 증가하여 고빈도 시행 시설의 치료 수준이 향상되고 있습니다.
• 수술 중 영상기술의 발전 : 형광 유도 수술과 최첨단 초음파를 포함한 수술 중 영상기술이 크게 발전하고 있습니다. 형광 이미징은 종양과 혈관을 강조하는 형광 염료를 적용하여 외과 의사가 암 조직과 비암 조직을 구별할 수 있도록 합니다. 이를 통해 종양을 보다 정확하고 포괄적으로 절제할 수 있으며, 이는 HPB 암 환자의 장기 생존율을 향상시키는 데 중요합니다.
• 전문 내시경 장비의 개발 : 주요 발전 중 하나는 간-담즙-췌장 영역에서 사용하기에 적합한 기능을 갖춘 전문 내시경 장비의 생산입니다. 내시경 내장형 초음파 프로브, ERCP(내시경적 역행성 담관 췌담관 조영술) 및 스텐트 삽입을 보다 쉽고 안전하게 시행할 수 있는 장비가 이에 해당합니다. 이를 통해 담관 및 췌장 질환에 대한 최소침습적 치료 및 진단 옵션이 생겨났으며, 많은 경우 개복 수술을 대체하고 있습니다.
• 첨단 에너지 절단 및 응고 장비의 도입 : 절단과 응고 기능을 통합한 새로운 에너지 장비는 획기적인 발전입니다. 고주파 및 초음파 에너지와 같은 기술을 채택한 이 장치는 열 확산과 그에 따른 미세 조직 구조의 손상을 줄이기 위해 설계되었습니다. 이를 통해 수술 중 출혈량을 줄이고, 췌장루 등의 합병증 발생 위험을 낮출 수 있습니다.
• 수술 계획 및 훈련을 위한 3D 프린팅 기술 : 수술 계획 및 훈련을 위해 환자별 해부학 모델을 3D 프린팅으로 제작하는 기술의 적용은 중요한 이정표가 되었습니다. 외과의사는 이제 수술 전에 환자의 췌장이나 간을 현실적으로 파악할 수 있는 모형을 사용하여 어려운 절제술을 리허설할 수 있게 되었습니다. 이를 통해 수술에 대한 확신을 높이고, 수술 시간을 단축하며, 예기치 못한 합병증을 줄일 수 있다는 장점이 있습니다.

이러한 발전은 기존 방식에서 고도로 정교한 기술 기반 솔루션으로의 빠른 전환을 촉진함으로써 시장에 영향을 미치고 있습니다. 시각화 능력의 향상, 정확성, 환자별 기술에 대한 강조는 제조업체들에게 새로운 성장 기회를 열어주는 동시에 간췌담도 수술 치료의 우수성에 대한 새로운 기준을 확립하고 있습니다.

목차

제1장 주요 요약

제2장 시장 개요

• 배경과 분류
• 공급망

제3장 시장 동향과 예측 분석

• 업계 성장 촉진요인과 과제
• PESTLE 분석
• 특허 분석
• 규제 환경

제4장 세계의 간췌담도 외과용 수술기구 시장 : 종류별

• 매력 분석 : 종류별
• 내시경
• 스텐트
• 봉합 기구
• 문합
• 전기수술기구
• 외과용 시각화 기기
• 카테터
• 기타

제5장 세계의 간췌담도 외과용 수술기구 시장 : 용도별

• 매력 분석 : 용도별
• 개복 수술
• 최소침습 수술

제6장 지역 분석

제7장 북미의 간췌담도 외과용 수술기구 시장

• 북미의 간췌담도 외과용 수술기구 시장 : 종류별
• 북미의 간췌담도 외과용 수술기구 시장 : 용도별
• 미국의 간췌담도 외과용 수술기구 시장
• 멕시코의 간췌담도 외과용 수술기구 시장
• 캐나다의 간췌담도 외과용 수술기구 시장

제8장 유럽의 간췌담도 외과용 수술기구 시장

• 유럽의 간췌담도 외과용 수술기구 시장 : 종류별
• 유럽의 간췌담도 외과용 수술기구 시장 : 용도별
• 독일의 간췌담도 외과용 수술기구 시장
• 프랑스의 간췌담도 외과용 수술기구 시장
• 스페인의 간췌담도 외과용 수술기구 시장
• 이탈리아의 간췌담도 외과용 수술기구 시장
• 영국의 간췌담도 외과용 수술기구 시장

제9장 아시아태평양의 간췌담도 외과용 수술기구 시장

• 아시아태평양의 간췌담도 외과용 수술기구 시장 : 종류별
• 아시아태평양의 간췌담도 외과용 수술기구 시장 : 용도별
• 일본의 간췌담도 외과용 수술기구 시장
• 인도의 간췌담도 외과용 수술기구 시장
• 중국의 간췌담도 외과용 수술기구 시장
• 한국의 간췌담도 외과용 수술기구 시장
• 인도네시아의 간췌담도 외과용 수술기구 시장

제10장 기타 지역(ROW)의 간췌담도 외과용 수술기구 시장

• ROW의 간췌담도 외과용 수술기구 시장 : 종류별
• ROW의 간췌담도 외과용 수술기구 시장 : 용도별
• 중동의 간췌담도 외과용 수술기구 시장
• 남미의 간췌담도 외과용 수술기구 시장
• 아프리카의 간췌담도 외과용 수술기구 시장

제11장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석
• 시장 점유율 분석

제12장 기회와 전략 분석

• 밸류체인 분석
• 성장 기회 분석
• 세계의 간췌담도 외과용 수술기구 시장 최신 동향
• 전략 분석

제13장 밸류체인 전반에 걸친 주요 기업 개요

• 경쟁 분석
• Johnson & Johnson
• Medtronic
• Cook Medical
• B. Braun
• Olympus Corporation
• Hobbs Medical
• TeleMed Systems
• Comepa
• Boston Scientific
• CONMED

제14장 부록

영문목차

The future of the global hepato-pancreatic-biliary surgery surgical device market looks promising with opportunities in the open surgery and minimally invasive surgery markets. The global hepato-pancreatic-biliary surgery surgical device market is expected to grow with a CAGR of 7.4% from 2025 to 2031. The major drivers for this market are the increasing prevalence of liver diseases, the rising demand for minimally invasive procedures, and the growing advancements in surgical technologies.

• Lucintel forecasts that, within the type category, endoscopic is expected to witness the highest growth over the forecast period.
• Within the application category, minimally invasive surgery is expected to witness higher growth.
• In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Hepato-Pancreatic-Biliary Surgery Surgical Device Market

The hepato-pancreatic-biliary surgery surgical device market is being redefined by a number of major emerging trends that are fundamentally transforming the way these intricate procedures are conducted. The trends are shifting the field in the direction of more precision, enhanced patient outcomes, and greater efficiency. The emphasis is on the integration of technology into each aspect of the process of surgery, from planning to delivery and recovery. This transformation is both motivated by the necessity to cope with the high complexity of HPB surgery and by the overall trend in healthcare to shift towards less invasive and more efficient treatments.

• Robotic and Augmented Reality Assisted Surgery: There is a strong trend towards the application of robotic surgery systems that provide greater dexterity, accuracy, and a stable view of the operating field. This is especially important for complex HPB procedures. In addition, augmented reality is being incorporated to superimpose patient-specific information, including tumor locations and vessel pathways, onto the real-time surgical view. The effect is decreased surgical tremors, more control in small areas, and a better-informed surgical decision-making process.
• Advanced Energy and Vessel Sealing Devices: A significant future trend is the creation of next-generation energy devices and vessel sealing devices. These instruments employ newer technologies such as radiofrequency ablation, ultrasonic energy, and cryoablation to accurately cut tissue and seal vessels with minimal thermal impact on surrounding healthy tissue. This is important in HPB surgeries, which are highly vascular. The effect is a major reduction in intra-operative blood loss, less surgical time, and quicker patient recovery.
• Artificial Intelligence and Machine Learning Integration: AI and machine learning are being integrated into HPB surgical devices more and more. AI algorithms can be used to analyze pre-operative imaging scans to establish precise 3D models for surgical planning. In the course of the procedure, machine learning can offer real-time feedback about tissue characteristics and recommend the best surgical routes. The effect is highly individualized and safer surgery, with AI functioning as a co-pilot to support the surgeon, decreasing the risk of complications.
• Patient-Specific and Custom Implants: Personalized medicine is growing in HPB surgery with the creation of patient-specific implants and surgical guides. Through the use of 3D printing and high-tech imaging, surgeons are able to design custom stents, guides, and models that precisely fit a patient's anatomy. This is especially necessary for complicated cases where anatomical variations are present. The effect is an improved, more accurate, and less invasive surgical procedure, which can result in improved outcomes and reduced post-operative complications.
• Evolution of Single-Port and NOTES Devices: In contrast to multiple ports utilized in conventional laparoscopic surgery, there is a growing trend towards single-port access and NOTES in order to minimize incision and post-operative pain. This necessitates the creation of highly articulated, flexible, and specially designed surgical instruments that are capable of operating with precision through a single, small cut or a natural body opening. The effect is a yet less invasive technique, with decreased scarring and an even quicker recovery period for patients.

These new trends are revolutionizing the HPB surgical device market by ensuring procedures become safer, more accurate, and less invasive. The emphasis on intelligence, customizability, and minimal access is changing the game, bringing new entrants, and giving rise to a new breed of surgical tools. This transformation ultimately serves patients by enhancing their surgery experience and long-term health outcomes.

Recent Developments in the Hepato-Pancreatic-Biliary Surgery Surgical Device Market

The market hepato-pancreatic-biliary surgery surgical device is going through a series of major developments that are increasing the technology and its application. These developments, which are the outcome of technological advancements as well as a demand for enhanced and minimally invasive treatments, are revolutionizing the specialty area of this highly specialized surgery. The net result of all of these advances is a maturing, diversified market able to meet an expanded set of complex clinical needs.

• Introduction of Next-Generation Robotic Systems: One major advancement is the introduction of new robotic surgical systems that are specifically designed for HPB surgeries. These platforms have enhanced articulation, haptic feedback, and high-resolution imaging, which provide surgeons with unparalleled control and visualization during intricate surgeries. The result is a dramatic rise in the rate of robotic surgery adoption for liver and pancreatic resections and an improved standard of care in high-volume institutions.
• Advances in Intraoperative Imaging: There has been a huge advancement in intraoperative imaging modalities, including fluorescence-guided surgery and state-of-the-art ultrasound. Fluorescence imaging involves the application of a fluorescent dye that highlights tumors and blood vessels, enabling the surgeon to distinguish between cancerous and noncancerous tissue. The effect is a more accurate and comprehensive resection of the tumor, and this is important for enhancing long-term survival among HPB cancer patients.
• Specialized Endoscopic Devices: One of the major developments is the manufacture of specialized endoscopic equipment with better features for HPB uses. These consist of endoscopes with internal ultrasound probes and equipment to conduct ERCP and stenting more easily and safely. The result is a less invasive therapy and diagnostic option for bile duct and pancreatic disease, replacing open surgery in most instances.
• Introduction of Advanced Energy Dissection and Sealing Devices: New energy devices that integrate cutting and coagulation in one instrument have been a significant advancement. These devices, employing technologies such as radiofrequency or ultrasonic energy, are made to reduce heat spread and resultant damage to fine tissue structures. The result is a reduced blood loss during surgery and lower chances of complications such as a pancreatic fistula.
• 3D Printing for Surgical Planning and Training: Application of 3D printing to produce patient-specific models of anatomy for surgical planning and training has been an important milestone. Surgeons can now rehearse difficult resections on a realistic, graspable model of a patient's pancreas or liver prior to surgery. The benefit is enhanced surgical confidence, shorter operating time, and fewer unexpected complications.

These advancements are influencing the market by facilitating a fast evolution from conventional approaches to extremely sophisticated, technology-based solutions. The emphasis on enhanced visualization, accuracy, and patient-specific techniques is opening up new opportunities for growth for manufacturers and establishing a new benchmark for excellence in HPB surgical treatment.

Strategic Growth Opportunities in the Hepato-Pancreatic-Biliary Surgery Surgical Device Market

The hepato-pancreatic-biliary surgery surgical device market offers a number of strategic opportunities for growth, fueled by technology innovation and the increasing need for less painful and more efficient treatments. These opportunities are centered on the expansion of sophisticated surgical devices into new geographies and applications. Those firms that can position themselves strategically to take advantage of these opportunities will be able to establish a strong competitive foothold. The challenge is to offer solutions that address the sophisticated requirements of surgeons, as well as offering real benefits to patients and healthcare systems.

• Growth in Robotic Surgery and Associated Consumables: The fast take-up of robotic surgery platforms is a significant strategic growth opportunity. Firms can leverage this by not only selling the robotic equipment itself but also offering highly specialized, high-margin consumables and instruments needed for each procedure. The model is one of recurring revenue. The effect is a move away from a single capital sale to a repeatable business model with a consistent stream of revenues from disposables.
• Expansion in Advanced Therapeutic Endoscopy and Diagnostics: There is increasing potential in advanced endoscopic treatments for HPB diseases. These involve endoscopic ultrasound equipment, ERCP, and Chol angioscopy. Businesses can expand by designing and selling next-generation endoscopes and accessories that enable both diagnosis and treatment in a single procedure, which is minimally invasive. The effect is a dramatic decrease in demand for open surgery and a new high-demand market segment with a huge requirement for specialized equipment.
• Emerging Economy Market Penetration: With better healthcare infrastructure in India and China, there is an enormous untapped market for HPB surgical devices. The strategic play is to introduce cost-effective, but quality, devices that are compatible with these markets. This can include creating simplified models of sophisticated products or offering extensive training programs to introduce the product. The effect is access to a huge patient base and a new source of long-term revenue.
• Emphasis on Liver Transplantation Tools: Liver transplant is a highly technical and life-threatening procedure involving very sophisticated surgical instruments. With the increasing volume of liver transplants being performed worldwide, there is a strategic opportunity for growth. Businesses have the opportunity to develop and market a comprehensive range of products for liver transplantation, including advanced clamps, energy tools, and fluid management systems. The impact is a migration into a high-value, specialized market with a high clinical need and a high barrier to entry.
• Device Development for Bariatric and Metabolic Surgery: Bariatric and metabolic surgery, involving operations on the pancreas and biliary system, is a growth area. The strategic opportunity is to create devices specifically designed for the singular anatomical complexities of these procedures. These consist of staplers, sealants, and access ports that are specifically designed for use in patients who have a higher body mass index. The effect is a new segment in the market that is fueled by the global obesity problem.

These opportunities are shaping the market through innovation and diversification. The emphasis on emerging economies and new applications is growing the size of the overall market and decreasing its dependence on traditional hospital facilities. The trend toward more specialized and integrated solutions is aiding companies in positioning themselves for long-term success as the complexion of complex surgical care continues to change.

Hepato-Pancreatic-Biliary Surgery Surgical Device Market Driver and Challenges

The hepato-pancreatic-biliary surgery surgical device market is influenced by a combination of complex drivers and challenges. The key drivers are driving the market, such as an increase in HPB disease incidence, advancements in technology, and an increase in the demand for minimally invasive procedures. Yet, primary challenges like the premium price of sophisticated devices, the requirement of significant surgeon training, and the superior complexity of the operations may hamper its growth and uptake.

The factors responsible for driving the hepato-pancreatic-biliary surgery surgical device market include:

1. Spreading Incidence of HPB Disorders: One of the main drivers is the increasing global incidence of diseases such as liver and pancreatic cancer, gallstones, and pancreatitis. These are commonly associated with lifestyle and an aging population, thus forming a stable and growing patient base. The increasing disease burden is a strong and sustained request for surgical devices for diagnosis and treatment.

2. Technology Improvements in Surgical Instruments: Ongoing innovation in surgical instruments is a primary driver. The introduction of next-generation robotic systems, 4K visualization, and more accurate energy and sealing instruments is enhancing outcomes, decreasing recovery, and increasing the number of procedures that can be done. These improvements are making the technology increasingly appealing to surgeons and hospitals.

3. Increasing Demand for Minimally Invasive Surgery: There is a worldwide movement toward minimally invasive surgeries because of their advantages, such as the smaller cuts, less pain, shorter stay in the hospital, and quicker recovery. This is an important market driver because it drives demand for specialized laparoscopic and robotic equipment used for these procedures.

4. Growing Medical Tourism: Increased medical tourism, which involves patients traveling to other nations in order to receive high-quality and frequently less expensive surgical procedures, is a market driver in some geographies. This produces a demand for sophisticated HPB surgical devices in popular destinations for medical tourism, where facilities must provide cutting-edge technology in order to entice patients.

5. Rising Healthcare Spending: The key driver is increasing healthcare spending, especially in developing economies. As governments and private payers spend more money on healthcare, hospitals have greater financial resources to invest in advanced surgical equipment and facilities. This is making complex HPB surgery available to a larger patient base.

Challenges in the hepato-pancreatic-biliary surgery surgical device market are:

1. Exorbitant Expense of Advanced Surgical Systems: One of the major challenges is the high upfront investment and upkeep expense of advanced surgical systems, especially robotic platforms. This can act as a deterrent to their use in smaller hospitals and health systems in resource-poor countries with tight budgets. The expense of consumables is also contributing to the cost of the procedure.

2. Extensive Surgeon Training Needed: HPB surgery is among the most intricate surgical specialties, and the use of sophisticated devices requires extensive and continuous training. Absence of standardized training and a lengthy learning curve can be a potent hurdle to the dissemination of new technologies, and it can also result in greater possibilities of complications if the surgeon is not well-trained.

3. Regulatory and Reimbursement Barriers: The market is challenged by intricate regulatory clearance procedures for emerging devices, which are time-consuming and costly. Inconsistent reimbursement procedures between regions and countries also create uncertainty for makers and can restrict the financial feasibility of emerging products, which can hinder innovation.

In summary, the HPB surgery surgical device marketplace is fueled by robust clinical and technological drivers but is hampered by formidable economic and logistical hurdles. The future success of the market will be contingent on the development of less expensive, intuitive, and clinically supported devices, as well as on enhanced education and training to facilitate broad and safe use of the technology.

List of Hepato-Pancreatic-Biliary Surgery Surgical Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies hepato-pancreatic-biliary surgery surgical device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the hepato-pancreatic-biliary surgery surgical device companies profiled in this report include-

• Johnson & Johnson
• Medtronic
• Cook Medical
• B. Braun
• Olympus Corporation
• Hobbs Medical
• TeleMed Systems
• Comepa
• Boston Scientific
• CONMED

Hepato-Pancreatic-Biliary Surgery Surgical Device Market by Segment

The study includes a forecast for the global hepato-pancreatic-biliary surgery surgical device market by type, application, and region.

Hepato-Pancreatic-Biliary Surgery Surgical Device Market by Type [Value from 2019 to 2031]:

• Endoscopic
• Stents
• Suture Equipment
• Anastomose
• Electrosurgical Instrument
• Surgical Visualization Equipment
• Catheter
• Others

Hepato-Pancreatic-Biliary Surgery Surgical Device Market by Application [Value from 2019 to 2031]:

• Open Surgery
• Minimally Invasive Surgery

Country Wise Outlook for the Hepato-Pancreatic-Biliary Surgery Surgical Device Market

The international market for hepato-pancreatic-biliary surgery surgical device is a fast-changing area of medical technology fueled by the rising incidence of liver, pancreas, and biliary diseases. Recent advances are primarily centered on improving the accuracy, safety, and efficacy of complicated HPB surgery. This development is characterized by dramatic movement away from conventional open surgery and towards minimally invasive technologies, such as laparoscopic and robot-assisted operations. These technologies are enhancing patient outcomes, diminishing recovery periods, and making advanced surgical care more accessible in various healthcare systems worldwide.

• United States: The US market is at the forefront of technological innovation and adoption of cutting-edge HPB surgical equipment. Recent advances are aimed at implementing robotic surgical systems and enhanced visualization technology, including 4K and 3D imaging, to improve surgical accuracy. The market is also witnessing a trend toward advanced energy devices and hemostatic sealants to reduce blood loss and enhance surgical success. Availability of a strong healthcare infrastructure and benevolent reimbursement policies are also fast-tracking the uptake of these advanced technologies.
• China: The Chinese HPB surgical device market is growing at a very fast pace due to a growing healthcare infrastructure and huge patient population. Recent trends involve a robust effort from local firms to develop affordable, high-quality surgical equipment to cut down on imports. Local medical device manufacturing is given an impetus by the government, along with an increasing demand for minimally invasive surgery. The market is also witnessing growth in the number of hospitals adopting advanced laparoscopic and robotic systems, which is driving the demand for a complete array of associated devices.
• Germany: The German market is dominated by a keen focus on clinical excellence, quality, and demanding regulatory requirements. Recent trends are geared to evolve existing technology to optimize surgical workflow and patient safety. German manufacturers place great emphasis on precision engineering, and the market has a high uptake of high-definition endoscopes and state-of-the-art electrosurgical instruments. The nation's strong research and development infrastructure is also helping to create next-generation surgical instruments that are combined with robotics and AI for enhanced autonomy and precision.
• India: The Indian HPB surgical device market is set to experience strong growth, fueled by growing health awareness and an increase in the incidence of surgical procedures being performed. Recent advances aim to address the need for low-cost, yet dependable, devices. Although the market remains preponderantly occupied by conventional surgical instruments, there is an increasing tendency to accept minimally invasive technologies in large city hospitals. Efforts by the government to enhance healthcare infrastructure and an increase in the rate of medical tourism are opening up new avenues for manufacturers of conventional as well as high-tech surgical instruments.
• Japan: The Japanese market is famous for its requirement for high-quality, compact, and technologically sophisticated medical devices. Current advances are aimed at innovations that enhance surgical safety and minimize patient burden. This encompasses the creation of new visualization systems with improved fluorescence imaging and advanced endoscopes with better maneuverability. The market is also witnessing a robust focus on robotic surgery systems and devices that assist in complex surgeries with improved precision. There is a robust interplay between clinicians and manufacturers to create highly specialized equipment.

Features of the Global Hepato-Pancreatic-Biliary Surgery Surgical Device Market

• Market Size Estimates: Hepato-pancreatic-biliary surgery surgical device market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Hepato-pancreatic-biliary surgery surgical device market size by type, application, and region in terms of value ($B).
• Regional Analysis: Hepato-pancreatic-biliary surgery surgical device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the hepato-pancreatic-biliary surgery surgical device market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the hepato-pancreatic-biliary surgery surgical device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the hepato-pancreatic-biliary surgery surgical device market by type (endoscopic, stents, suture equipment, anastomose, electrosurgical instrument, surgical visualization equipment, catheter, and others), application (open surgery and minimally invasive surgery), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Hepato-Pancreatic-Biliary Surgery Surgical Device Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 Endoscopic: Trends and Forecast (2019-2031)
• 4.4 Stents: Trends and Forecast (2019-2031)
• 4.5 Suture Equipment: Trends and Forecast (2019-2031)
• 4.6 Anastomose: Trends and Forecast (2019-2031)
• 4.7 Electrosurgical Instrument: Trends and Forecast (2019-2031)
• 4.8 Surgical Visualization Equipment: Trends and Forecast (2019-2031)
• 4.9 Catheter: Trends and Forecast (2019-2031)
• 4.10 Others: Trends and Forecast (2019-2031)

5. Global Hepato-Pancreatic-Biliary Surgery Surgical Device Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Open Surgery: Trends and Forecast (2019-2031)
• 5.4 Minimally Invasive Surgery: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Hepato-Pancreatic-Biliary Surgery Surgical Device Market by Region

7. North American Hepato-Pancreatic-Biliary Surgery Surgical Device Market

• 7.1 Overview
• 7.2 North American Hepato-Pancreatic-Biliary Surgery Surgical Device Market by Type
• 7.3 North American Hepato-Pancreatic-Biliary Surgery Surgical Device Market by Application
• 7.4 United States Hepato-Pancreatic-Biliary Surgery Surgical Device Market
• 7.5 Mexican Hepato-Pancreatic-Biliary Surgery Surgical Device Market
• 7.6 Canadian Hepato-Pancreatic-Biliary Surgery Surgical Device Market

8. European Hepato-Pancreatic-Biliary Surgery Surgical Device Market

• 8.1 Overview
• 8.2 European Hepato-Pancreatic-Biliary Surgery Surgical Device Market by Type
• 8.3 European Hepato-Pancreatic-Biliary Surgery Surgical Device Market by Application
• 8.4 German Hepato-Pancreatic-Biliary Surgery Surgical Device Market
• 8.5 French Hepato-Pancreatic-Biliary Surgery Surgical Device Market
• 8.6 Spanish Hepato-Pancreatic-Biliary Surgery Surgical Device Market
• 8.7 Italian Hepato-Pancreatic-Biliary Surgery Surgical Device Market
• 8.8 United Kingdom Hepato-Pancreatic-Biliary Surgery Surgical Device Market

9. APAC Hepato-Pancreatic-Biliary Surgery Surgical Device Market

• 9.1 Overview
• 9.2 APAC Hepato-Pancreatic-Biliary Surgery Surgical Device Market by Type
• 9.3 APAC Hepato-Pancreatic-Biliary Surgery Surgical Device Market by Application
• 9.4 Japanese Hepato-Pancreatic-Biliary Surgery Surgical Device Market
• 9.5 Indian Hepato-Pancreatic-Biliary Surgery Surgical Device Market
• 9.6 Chinese Hepato-Pancreatic-Biliary Surgery Surgical Device Market
• 9.7 South Korean Hepato-Pancreatic-Biliary Surgery Surgical Device Market
• 9.8 Indonesian Hepato-Pancreatic-Biliary Surgery Surgical Device Market

10. ROW Hepato-Pancreatic-Biliary Surgery Surgical Device Market

• 10.1 Overview
• 10.2 ROW Hepato-Pancreatic-Biliary Surgery Surgical Device Market by Type
• 10.3 ROW Hepato-Pancreatic-Biliary Surgery Surgical Device Market by Application
• 10.4 Middle Eastern Hepato-Pancreatic-Biliary Surgery Surgical Device Market
• 10.5 South American Hepato-Pancreatic-Biliary Surgery Surgical Device Market
• 10.6 African Hepato-Pancreatic-Biliary Surgery Surgical Device Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Hepato-Pancreatic-Biliary Surgery Surgical Device Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 Johnson & Johnson
  • Company Overview
  • Hepato-Pancreatic-Biliary Surgery Surgical Device Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Medtronic
  • Company Overview
  • Hepato-Pancreatic-Biliary Surgery Surgical Device Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Cook Medical
  • Company Overview
  • Hepato-Pancreatic-Biliary Surgery Surgical Device Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 B. Braun
  • Company Overview
  • Hepato-Pancreatic-Biliary Surgery Surgical Device Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Olympus Corporation
  • Company Overview
  • Hepato-Pancreatic-Biliary Surgery Surgical Device Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Hobbs Medical
  • Company Overview
  • Hepato-Pancreatic-Biliary Surgery Surgical Device Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 TeleMed Systems
  • Company Overview
  • Hepato-Pancreatic-Biliary Surgery Surgical Device Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.9 Comepa
  • Company Overview
  • Hepato-Pancreatic-Biliary Surgery Surgical Device Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.10 Boston Scientific
  • Company Overview
  • Hepato-Pancreatic-Biliary Surgery Surgical Device Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.11 CONMED
  • Company Overview
  • Hepato-Pancreatic-Biliary Surgery Surgical Device Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us